The real argument in terms of medical devices involves when and how new devices will be recommended, in preference to older ones.
Covering all areas of medical technology, and the public policies under which they're paid for. From networked systems and electronic medical records to gadgets, breakthroughs, and research.
Of course the industry is cherry-picking risks. They're selling insurance, not care. Insurance is not care. Insurance is if. Care means when.
Amalga, at launch, will be one of the big vendors in the space.
As any society eats more meat and fat, their rate of heart attack goes up. Trouble is most of us are immune to the easy solution. Eat less, especially fatty meat, exercise more.
We're conditioned to think sugar means calories. Then we learn sugar may mean no calories. We cut back our normal response to calories. Thus it takes more food to get the response.
Have medical devices become like the oil industry or the payday lenders? Do they need an image campaign to stay afloat against the incoming political fire?
Someone in health care is finally betting the company on open source. Misys hopes it will be a winning bet.
New studies involving enzymes, proteins and genes may well yield new clues as to how the diabetes progresses and how to deal with it. So this "failure" actually represents an enormous opportunity for the research community.
Are you ready to do a remote diagnosis?
Medical inflation is a global phenomenon. Whether you run it privately or through the government, costs are rising with demand and complexity.